NMP22 Test Kit: Marketed

Cleveland Clinic researchers presented a comparison of laboratory and office-based tests for detecting bladder cancer in a population of 239 patients, 77 of whom were known to have bladder cancer. NMPS's NMP22 lab test had a specificity of 79 percent and a sensitivity of 88 percent, compared to Bion's BTA TRAK lab test (59 percent and 79 percent, respectively) and Bion's BTA stat office test (79 percent for each measure). The researchers concluded that NMP22 is the superior lab test but that the qualitative BTA stat office test has a similar specificity and sensitivity to the lab tests. ...